Neuropeptide Transmitters and their Receptors Flashcards

1
Q

Dale’s Hypothesis?

A

A single neurone stoers and releases neurotransmitter(s) from all of its terminals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What hypothesis did Burnstok devise?

A

The co-transmitter hypothesis. (NA/5HT) (NA/ATP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name 5 neuropeptide families.

A

1) Substance P and Neurokinins
2) Enkephalins
3) Neuropeptide Y
4) Vasoactive intestinal Polypeptide
5) Calcitonin Gene Related Peptide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the production of all bioactive peptide.

A

Synthesised in the cell body, enzymatically cleaved from larger, inactive precursor peptides in the WR, transferred to the Golgi for packing and transported to release sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Are levels of neuropeptide expression constant?

A

No - they can vary depending on stage of development or any pathologies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain NPY production.

A
Produced from 4 exons in 1 gene. 
There is regulation at...
...transcription
...translation
...post-transcriptional processing (plus amide group to make NPY active)

CPON (C-terminal peptide of NPY) is also produced, packaged, released and degraded as NPy but is inactive!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain Sp and NK production.

A

Preprotachykinin gene I - SP with or without NKA, NPK, NPY

Preprotachykinin gene II - NKB.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which receptors do SP, NKA and NKB act on?

A

SP and NKA - NK1 and 2

NKB - NK3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are neuropeptides degraded?

A

Extracellularly, by peptidases…that hydrolyse numerous unrelated peptides.

eg enkephalinase - degrades anything with a hydrophobic amino acid then tyr/phe.

Inactivates NKA, SP, NKB and NPY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does post secretory processing achieve?

A

Modifies receptor selectivity - NPY is cleaved by DPP4…removes 2 amino acids to make it selective for Y2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Do all target tissues have the same repertoires of degrading enzymes?

A

NO - different target tissues have different repertoires of degrading enzymes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain the release of Co-transmitters.

A

Neuropeptides are stored in large dense core vesicles.
Classic transmitters are stored in small (clear) synaptic vesicles (SSV).
At low frequencies (local Ca++ elevation), SSV exocytosis.
At high frequecies (general Ca++ elevation)- corelease of LDCV and SSVs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explainco release of VIP and ACh.

A

Parasympathetic nerves innervating salivary glands.
Low freq - Ach release on M receptors = sailvary secretion.
High freq - VIP aswell, vascular dilation and increased ACh release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain NPY and NA co release.

A

In Sympathetic Nerves innervating SM.
Low freq - NA = vasoconstriction
High, INTERMITTENT freq: NPY release.

Low [NPY] = potentiates Na induced vasoconstriction
High [NPY] = Y1 vasoconstriction and inhibiton of NA and NPY release via Y2..

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Are all neuropeptides co-released?

A

NO!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do neuropeptides have their effect?

A

Slowly, via GPCRs, initiating signalling cascades.

17
Q

NPY receptors?

A

Gi/o - decrease cAMP.

NPY - greatest selectivity for Y2 receptor.

18
Q

What effects does NPY have?

A

Stimulates feeding

inhibitory (anxiolytic, sedative = Y1. antiepileptic = Y2).

19
Q

Neurokinin receptor?

A

Nk1 = greatest affinity for SP
NK2 = NKA
NK3 - NKB

Couples Gq…increase [ca++]

20
Q

What do Sp and NKA mediate in the spinal cord?

A

PAIN

21
Q

Name some future therapeutic targets.

A

Y1 antagonist…antihypertensive, antiepileptic, anti obestiy and anti inflammatory.
NK1/2 anatag - analgesic, antihyperalgesic
DPP4 inhibitor - increase half life of GLP1…increase glucose dependant insulin release and pancreatic beta cell number.